Download the article in PDF format *** On July 21, 2022, the United Kingdom’s Competition and Markets Authority (CMA) fined pharmaceutical companies Pfizer Inc. and Flynn Pharma Limited £63 million and £6 million respectively. The fines levied against these companies are the result of them abusing their market position as a means to overcharge the … Continue reading Pfizer/Flynn medicine monopoly and the NHS: A corporate exploitation of public resources in the United Kingdom →